Bayer gets FDA rebuke for drug production in Germany
February 14, 2018 at 06:19 AM EST
FRANKFURT, Feb 14 (Reuters) - Bayer said it had received a warning letter from the U.S. Food and Drug Administration over how it handled production of some drugs at its Leverkusen, Germany headquarters.